Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
Bangladesh · Delayed Price · Currency is BDT 102.50
-1.50 (-1.44%)
At close: Jan 22, 2026
Beacon Pharmaceuticals Market Cap
Beacon Pharmaceuticals has a market cap or net worth of 23.68 billion as of January 23, 2026. Its market cap has decreased by -21.03% in one year.
Market Cap
23.68B
Enterprise Value
30.18B
Revenue
11.58B
Ranking
n/a
PE Ratio
41.54
Stock Price
102.50
Market Cap Chart
Since August 12, 2010, Beacon Pharmaceuticals's market cap has increased from 19.93B to 23.68B, an increase of 18.79%. That is a compound annual growth rate of 1.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 23.68B | -2.01% |
| Dec 30, 2025 | 24.16B | -23.03% |
| Dec 30, 2024 | 31.39B | -44.53% |
| Dec 28, 2023 | 56.60B | -14.34% |
| Dec 29, 2022 | 66.07B | 17.50% |
| Dec 30, 2021 | 56.23B | 210.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 190.76B |
| Beximco Pharmaceuticals PLC. | 50.95B |
| Renata | 47.40B |
| Unilever Consumer Care | 42.22B |
| The ACME Laboratories | 15.62B |
| The IBN SINA Pharmaceutical Industry | 10.13B |
| Asiatic Laboratories | 6.66B |
| Orion Pharma | 6.51B |